Ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetate → {5-[3,3-Bis-(4-methyl-cyclohexyl)-ureido]-[1,3,4]thiadiazol-2-ylsulfanyl}-acetic acid

Beteiligte Stoffe

Rolle	Name	HCID	Einwaage
Edukt	Ethyl 2-[(5-amino-1,3,4-thiadiazol-2-yl)sulfanyl]acetate	HCID 351912	—
Edukt	4-methyl-N-(4-methylcyclohexyl)cyclohexan-1-amine	HCID 417228	—
Edukt	{5-[3,3-Bis-(4-methyl-cyclohexyl)-ureido]-[1,3,4]thiadiazol-2-ylsulfanyl}-acetic acid ethyl ester	HCID 66871997	—
Produkt	{5-[3,3-Bis-(4-methyl-cyclohexyl)-ureido]-[1,3,4]thiadiazol-2-ylsulfanyl}-acetic acid	HCID 57883670	—

Reaktionsschritte

{5-[3,3-Bis-(4-methyl-cyclohexyl)-ureido]-[1,3,4]thiadiazol-2-ylsulfanyl}-acetic acid ethyl ester prepared from bis-(4-methyl-cyclohexyl)-amine and ethyl-2-[5-amino-1,3,4-thiadiazol-2-yl-thio]acetate as described in general procedures (A) and (B). Hydrolysis using general procedure (F) gave the title compound.

Herkunft & Nachweise

DOI	10.6084/m9.figshare.5104873.v1
Patentnummer	US07598391B2
Quelldatensatz	uspto-grants-2009_10
ORD ID	ord-2369249576564943af6cead12f7eb8bd
Quellennotiz	uspto-grants-2009_10